Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and Paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitions. [electronic resource]
Producer: 20120823Description: 150-6 p. digitalISSN:- 1941-7632
- Aged
- Biomarkers -- blood
- Blood Vessel Prosthesis Implantation
- Creatine Kinase -- blood
- Drug-Eluting Stents
- Everolimus
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Myocardial Infarction -- diagnosis
- Paclitaxel -- administration & dosage
- Postoperative Complications -- diagnosis
- Practice Guidelines as Topic
- Prognosis
- Prospective Studies
- Reference Standards
- Sensitivity and Specificity
- Sirolimus -- administration & dosage
- Survival Analysis
- Troponin -- blood
- United States
- United States Food and Drug Administration
- World Health Organization
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.